Perioperative cardiac events can be a major consequence of surgery. The American College of Cardiology Foundation/American Heart Association has set out guidelines to aid physicians in identifying patients at the highest risk for these events. The guidelines do recommend for some patients to undergo noninvasive cardiac stress testing for further risk stratification, but their sensitivity and specificity for predicting cardiac events is not optimal. With more data emerging of the superior performance of computed coronary tomography angiography (CCTA) compared to noninvasive stress testing, CCTA could be more useful in risk stratification for these patients.
Introduction
Major perioperative cardiac events occur in approximately 1% of non-cardiac surgeries, increasing patient morbidity, mortality, and length of stay. 1 According to the American College of Cardiology Foundation/American Heart Association (ACCF/AHA) 2007 Guidelines on Perioperative Cardiovascular Evaluation, non-invasive cardiac stress testing should be considered for patients undergoing moderate or high-risk surgery with poor functional capacity and at least one clinical risk factor. The intent of the testing is to further refine risk assessment for perioperative cardiac events and to determine the need for interventions prior to surgery aimed at reducing such a risk. The presence of obstructive coronary artery disease increases the risk of perioperative cardiac events. Although the obstructive lesion itself is often not the cause of the cardiac event, the lesion is a marker for advanced coronary atherosclerotic plaque burden and, among them, unstable plaques that are thought to lead to many of these events. 2 In addition to plaque type, other factors including alterations in coronary blood flow, changes in hemostasis, neurohormonal dysregulation, or other environmental stressors are typically required to incite an acute coronary event. 3 Surgery produces inflammation, catecholamine release, and a hypercoagulable state which can precipitate plaque rupture, thrombosis, and myocardial infarction (MI). 1 Dawood et al. showed, through autopsy review, that the pathophysiology of a fatal perioperative myocardial infarction is very similar to nonoperative events. They compared the histopathology of myocardial infarction in patients who underwent surgery as well as those who did not. Plaque hemorrhage/rupture occurred in 55% of the perioperative group versus 40% of the non-operative patients (P=0.32), while thrombus without plaque disruption was noted in 29% versus 36% (P=0.59) of the perioperative versus non-operative patients, respectively. 4 A review of the literature reveals only fair sensitivity and specificity of current noninvasive cardiac stress modalities to predict cardiac events in perioperative patients. Kertai et al. performed a meta-analysis of 58 studies with 8119 patients to determine the operating characteristics (sensitivity and specificity) of a variety of non-invasive stress tests performed before surgery. When evaluating for the likelihood of perioperative cardiac death and non-fatal myocardial infarction in vascular surgery patients, dobutamine stress echocardiography had the lowest (most favorable) negative likelihood ratio (LR), 0.21, while radionuclide ventriculography had the highest positive LR, 5.56. 5 Beattie et al. in their meta-analysis of 68 studies of 10,049 patients compared thallium imaging to stress echocardiography and determined that stress echocardiography had a better positive LR (4.09 vs. 1.83) and negative LR (0.23 vs. 0.44) for predicting a postoperative cardiac event. 6 Based on these numbers, a patient with a moderate perioperative cardiac event risk of 6% would have a posttest probability of 21% with a positive preoperative stress echocardiography study and a risk of 1% with a negative study. More recently, computed coronary tomography angiography (CCTA) has emerged as a more sensitive test to non-invasively evaluate cardiac risk through imaging of the coronary arteries. Although there has only been limited experience with this modality in the perioperative setting, CCTA is able to accurately detect and exclude significant coronary artery disease (CAD) in many other clinical settings. A systematic review of 41 studies and 2500 patients with stable chest pain comparing CCTA to the gold standard diagnostic test, coronary angiography, found CCTA to have a sensitivity of 99% and specificity of 89% for detecting flow-limiting CAD defined as greater than 50% stenosis by quantitative analysis. This translates to a positive likelihood ratio of 9 and negative likelihood ratio of 0.01. between SPECT and CCTA for detecting more than 50% coronary artery stenosis. Using invasive coronary angiography as the reference standard, SPECT was 66% sensitive and 69% specific compared to the 96% sensitivity and 88% specificity of CCTA. 8 A few studies have explored the use of CCTA in patients undergoing non-coronary cardiac surgery. [9] [10] [11] [12] [13] In the largest cohort of 70 patients preparing for valvular surgery, CCTA was 100% sensitive and 92% specific for detecting more than 50% stenosis in the coronary arteries when compared to invasive coronary angiography. 9
Outcome: cardiac events Patients with a negative test had a much lower post-test probability of having an event. 15 Importantly, most of these studies included total mortality, but not cardiac mortality, as end points. If only cardiac mortality or myocardial infarction are considered, the event rate after a normal CCTA was zero even up to five years after testing. 16 Such negative predictive value is unmatched by other non-invasive tests. On the other hand, the specificity of only 41% produces a low positive LR (1.70) which means that a positive CCTA, using simply the presence of obstructive coronary artery disease, is a poor predictor of an impending major cardiac event. 15 To further investigate the negative predictive value of CCTA in low-to intermediate-risk patients (thrombolysis in myocardial infarction, TIMI 0-2) presenting to the ED with chest pain, Litt et al. randomized patients to a CCTA or usual care pathway. Of those studied in the CCTA pathway, 640 had a negative CCTA (less than 50% stenosis), and none of them died or had an MI within 30 days after presentation. 17 In addition, Hoffman et al. performed a multicenter study randomizing 1000 patients presenting to the ED with chest pain with any TIMI score to either standard ED evaluation or CCTA as first evaluation. Patients were followed for 28 days after discharge from the hospital. In the usual care pathway, there were 6 cases of acute coronary syndrome and only 2 in the CCTA group. Of note, the CCTA was positive for clinically significant disease in both of these patients, but they both had negative stress tests and were managed medically. In addition, there was no significant difference in number of catherizations, percutaneous intervention (PCI) or coronary artery bypass surgery (CABG) between each group. 18
Can we use computed coronary tomography angiography in the perioperative setting?
The ACCF released appropriate use criteria for CCTA most recently in 2010. The foundation rates CCTA as appropriate to detect CAD in intermediate risk patients. This refers to patients presenting with non-acute ischemic symptoms despite having an interpretable EKG or ability to exercise. 19 In addition, the ACCF recommends (while acknowledging uncertainty given the current body of evidence) using CCTA for preoperative evaluation on patients with less than 
Conclusions
Based on available data, CCTA is effective at excluding the presence of flow-limiting CAD and in identifying those patients with chest pain who are unlikely to have near-term coronary events. Absence of flow-limiting lesions appears to be a surrogate marker for low coronary atherosclerotic plaque burden and unstable coronary plaques. Given that stress echocardiography and MPI performance is, at best, only fair in risk-stratifying preoperative patients, and in other settings is inferior to CCTA, we suggest considering CCTA as an appropriate, and perhaps better way to stratify perioperative patients at risk for CAD if testing is indeed indicated (Table 1) . CCTA is both sensitive and specific for detecting angiographically apparent obstructive CAD. Although there are no studies on the perioperative patient, the data on CCTA in other settings suggest it should be considered as a reasonable and possibly superior substitute for other non-invasive modalities. A randomized control trial comparing CCTA to other modalities in the preoperative setting is warranted. 
